19th May 2015 08:20
LONDON (Alliance News) - Advanced Oncotherapy PLC on Tuesday said the radio frequency power tests conducted on its Coupled Cavity Linac unit have been completed at its testing facility at CERN in Switzerland in line with its expectations.
The units, created by ScandiNova Systems AB, generate the high power required to accelerate protons to speeds whereby they are able to effectively target cancer cells, the company said.
"In November last year we gave investors a clear pathway towards the delivery of our first LIGHT system, and I am delighted that we continue to deliver to this timetable on time and to budget, with the successful RF Power testing of the first CCL unit," said Advanced Oncotherapy Chief Executive Sanjeev Pandya.
"Our recent funding has provided the company with the financial security that we need to deliver our ground-breaking proton therapy technology which we expect will be treating patients in the heart of London in 2017," said Pandya.
Shares in Advanced Oncotherapy were down 3.3% to 9.55 pence on Tuesday.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
AVO.L